Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

NCT02878161 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate(necessary)
BIOLOGICAL: infliximab
BIOLOGICAL: etanercept
BIOLOGICAL: adalimumab
DRUG: leflunomide (permitted, not necessary)
DRUG: NSAIDs (permitted,not necessary)
DRUG: Glucocorticoids (permitted,not necessary)

Sponsor

Fen Li